Britain approves Moderna's Covid-19 vaccine for use | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Thursday
June 08, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
THURSDAY, JUNE 08, 2023
Britain approves Moderna's Covid-19 vaccine for use

Coronavirus chronicle

Reuters
08 January, 2021, 06:55 pm
Last modified: 08 January, 2021, 07:58 pm

Related News

  • Variant-adapted Covid vaccine wins first approval in Britain
  • Covid vaccine maker Moderna flags Japan ambition with sumo sponsorship
  • Moderna seeks FDA authorisation for second Covid booster for all adults
  • Moderna jabs to be given as boosters instead of Pfizer
  • Moderna could be ready to develop omicron booster in weeks: CEO

Britain approves Moderna's Covid-19 vaccine for use

Three Covid-19 vaccines have now been approved for use in Britain, with Pfizer//BioNTech’s shot and one developed by Oxford University and AstraZeneca already being rolled out

Reuters
08 January, 2021, 06:55 pm
Last modified: 08 January, 2021, 07:58 pm
Britain approves Moderna's Covid-19 vaccine for use

Britain's medical regulator on Friday approved Moderna's Covid-19 vaccine for use, the health ministry said, adding that it had agreed to purchase an additional 10 million doses of the shot as it eyed a spring rollout of the shot.

Three Covid-19 vaccines have now been approved for use in Britain, with Pfizer//BioNTech's shot and one developed by Oxford University and AstraZeneca already being rolled out.

The Moderna shot is not expected to play a part in the first stage of Britain's vaccine rollout. Britain now has 17 million doses of Moderna's vaccine on order, and supplies will begin to be delivered to the UK from the spring once Moderna expands its production capability.

"We have already vaccinated nearly 1.5 million people across the UK and Moderna's vaccine will allow us to accelerate our vaccination programme even further once doses become available from the spring," health minister Matt Hancock said.

Britain was the first to approve Pfizer's and AstraZeneca's vaccines as it bids to ramp up its vaccine rollout quickly but is behind some other major countries in giving the go-ahead to the Moderna shot.

Moderna's vaccine was 94% effective in preventing disease in late-stage clinical trials, and it has already been given regulatory approval for use in the United States, Canada, the European Union and Israel.

Britain is attempting to vaccinate the elderly, the vulnerable and frontline workers - around 15 million people - by mid-February, to ease a new strict lockdown imposed after a spike in cases to daily records.

Although Moderna's vaccine will not help meet that target, it will help ease supply constraints that Hancock has cited as being a limiting factor in the rollout.

"This is excellent news and a further crumb of comfort amid the huge levels of Covid-19 currently circulating around the UK," said Michael Head, Senior Research Fellow in Global Health at the University of Southampton.

"When these Moderna vaccines arrive, they will help to ease any bottlenecks or delays in the administration programme."

Top News

Moderna Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Collected
    No govt agency will file cases to harass others to ensure free, fair polls: Law minister
  • Photo: BSS
    Income Tax Bill 2023 placed in Parliament
  • Bangladesh must suspend pilot project to return Rohingyas to Myanmar: UN expert
    Bangladesh must suspend pilot project to return Rohingyas to Myanmar: UN expert

MOST VIEWED

  • Covid is no longer global health emergency: WHO
    Covid is no longer global health emergency: WHO
  • Federal police officers stand guard near the house of former Brazilian President Jair Bolsonaro, during a search operation at his home, in Brasilia, Brazil, 3 May, 2023. REUTERS/Adriano Machado
    Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • World Health Organization logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS/Dado Ruvic/Illustration//File Photo
    Covid here to stay but moving out of emergency phase: WHO
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India reports 12,591 new Covid cases today, 20% more than yesterday
  • People queue up outside a quick test centre to take their coronavirus disease (Covid-19) antigen rapid tests, in Singapore September 21, 2021. Photo :Reuters
    Singapore witnesses new Covid wave: ‘Cases are mostly mild’
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India logs 5,676 new Covid cases, active infections cross 37,000-mark

Related News

  • Variant-adapted Covid vaccine wins first approval in Britain
  • Covid vaccine maker Moderna flags Japan ambition with sumo sponsorship
  • Moderna seeks FDA authorisation for second Covid booster for all adults
  • Moderna jabs to be given as boosters instead of Pfizer
  • Moderna could be ready to develop omicron booster in weeks: CEO

Features

Our failure to prevent curious onlookers from gathering around the herds is a hindrance to mitigating human-elephant conflict. Photo: Mohammed Mostafa Feeroz

Bleak and desolate? The future of elephants in northern Bangladesh

3h | Earth
Apple does not need to make mixed reality seem exciting to get customers through its doors. They’re turning up in droves anyway, to buy new iPhones or to visit the Genius Bar for IT support. Photo: Bloomberg

Apple has 520 reasons its $3,499 headset will prevail

6h | Panorama
Md Shamsuddoha. Sketch: TBS

'Extreme heat waves are here to stay'

7h | Panorama
Kestopur’s residents have crafted fans for generations and provided it to Rajbari, Faridpur, Kustia, Madaripur, Dhaka and several other districts. Photo: Masum Billah

Talpakha: When novelty becomes necessity

11h | Panorama

More Videos from TBS

13 helpful tips to negotiate about job

13 helpful tips to negotiate about job

1h | TBS Career
Why did Messi turn away from Europe?

Why did Messi turn away from Europe?

2h | TBS SPORTS
Breaching the Kakhovka dam – who benefits?

Breaching the Kakhovka dam – who benefits?

6h | TBS World
The cost of rechargeable fan is increasing hourly due to heating and load shedding

The cost of rechargeable fan is increasing hourly due to heating and load shedding

9h | TBS Today

Most Read

1
bKash denied permission to pay $4.10 lakh for Argentina football partnership
Banking

bKash denied permission to pay $4.10 lakh for Argentina football partnership

2
Photo: Noor-A-Alam/TBS
Splash

The Night Dhaka did NOT vibe with Anuv Jain

3
Photo: TBS
Energy

2nd unit of Payra power plant to shut down over coal shortage

4
Country's first floating solar power plant connected to national grid
Energy

Country's first floating solar power plant connected to national grid

5
Photo: Screengrab from a video posted by a NSU student
Energy

'Will collapse any moment': NSU teachers, students raise concern after long power outage hit country's largest private uni

6
Photo: Salahuddin Ahmed Paulash/TBS
Energy

LPG price drops by Tk13.42 per kg

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]